Pharmacological modulation of GABAB receptors affects cocaine-induced seizures in mice

Psychopharmacology

Volumn 174, Issue 2, 2004, Pages 211-219

  Gasior, Maciej ^a,b   Kaminski, Rafal ^a,b   Witkin, Jeffrey M ^a,c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Anticonvulsant; Baclofen; Cocaine; GABA; Kindling; Seizures

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; AMINOPHYLLINE; BACLOFEN; COCAINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PENTETRAZOLE; PHACLOFEN; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; ENANTIOMER; KINDLING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOSPECIFICITY;

EID: 3142775770     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1743-0     Document Type: Article

References (48)

1. Andersen PH (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166:493-504
2. Benedito MA, Leite JR (1981) Baclofen as an anticonvulsant in experimental models of convulsions. Exp Neurol 72:346-351
3. Benowitz NL (1993) Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol 72:3-12
4. B receptor pharmacology. Annu Rev Pharmacol Toxicol 33:109-147
5. Bradford HF (1995) Glutamate, GABA and epilepsy. Prog Neurobiol 47:477-511
6. Cousins MS, Roberts DC, de Wit H (2002) GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend 65:209-220
7. Czuczwar SJ, Frey HH, Löscher W (1985a) Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agents. Eur J Pharmacol 108:273-280
8. Czuczwar SJ, Turski L, Chmielewska B, Turski WA, Kleinrok Z (1985b) Modification of the anticonvulsant activity of 2-amino-5-phosphonovalerate by agents affecting different neurotransmitter systems. Neuropharmacology 24:965-968
9. Czuczwar SJ, Janusz W, Wamil A, Kleinrok Z (1987) Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur J Pharmacol 144:309-315
10. De Sarro G, Palma E, Costa N, Marra R, Gratteri S, De Sarro A, Rotiroti D (2000) Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice. Neuropharmacology 39:2147-2161
11. Gasior M, Carter RB, Goldberg SR, Witkin JM (1997) Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. J Pharmacol Exp Ther 282:543-553
12. Gasior M, Ungard JT, Witkin JM (1999) Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J Pharmacol Exp Ther 290:1148-1156
13. Gasior M, Ungard JT, Witkin JM (2000) Chlormethiazole: effectiveness against toxic effects of cocaine in mice. J Pharmacol Exp Ther 295:153-161
14. Ginski M, Witkin JM (1994) Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists. Psychopharmacology 114:573-582
15. Holland KD, McKeon AC, Canney DJ, Covey DF, Ferrendelli JA (1992) Relative anticonvulsant effects of GABAmimetic and GABA modulatory agents. Epilepsia 33:981-986
16. Hosford DA, Wang Y, Liu CC, Snead III OC (1995) Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models. J Pharmacol Exp Ther 274:1399-1403
17. Itzhak Y, Martin JL (2000) Cocaine-induced kindling is associated with elevated NMDA receptor binding in discrete mouse brain regions. Neuropharmacology 39:32-39
18. Itzhak Y, Stein I (1992) Sensitization to the toxic effects of cocaine in mice is associated with the regulation of N-methyl-D-aspartate receptors in the cortex. J Pharmacol Exp Ther 262:464-470
19. Kaminski RM, Gasior M, Carter RB, Witkin JM (2003) Protective efficacy of neuroactive steroids against cocaine kindled-seizures in mice. Eur J Pharmacol 474:217-222
20. Karla R, Ebert B, Thorkildsen C, Herdeis C, Johansen TN, Nielsen B, Krogsgaard-Larsen P (1999) Synthesis and pharmacology of the baclofen homologues 5-amino-4-(4-chlorophenyl)pentanoic acid and the R- and S-enantiomers of 5-amino-3-(4-chlorophenyl)pentanoic acid. J Med Chem 42:2053-2059
21. B receptors. Pharmacol Ther 67:187-246
22. Khodorov B, Shishkova L, Peganov E, Revenko S (1976) Inhibition of sodium currents in frog Ranvier node treated with local anesthetics. Role of slow sodium inactivation. Biochim Biophys Acta 433:409-435
23. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649-661
24. Kofler M, Kronenberg MF, Rifici C, Saltuari L, Bauer G (1994) Epileptic seizures associated with intrathecal baclofen application. Neurology 44:25-27
25. Kolhatkar RB, Ghorai SK, George C, Reith ME, Dutta AK (2003) Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4- fluorobenzyl)piperidin-4-ylmethyl]amine. J Med Chem 46:2205-2215
26. Lason W (2001) Neurochemical and pharmacological aspects of cocaine-induced seizures. Pol J Pharmacol 53:57-60
27. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113
28. Matejovska I, Veliskova J, Velisek L (1998) Bicuculline-induced rhythmic EEG episodes: gender differences and the effects of ethosuximide and baclofen treatment. Epilepsia 39:1243-1252
29. Matsumoto RR (1989) GABA receptors: are cellular differences reflected in function? Brain Res Rev 14:203-225
30. Miller KA, Witkin JM, Ungard JT, Gasior M (2000) Pharmacological and behavioral characterization of cocaine-kindled seizures in mice. Psychopharmacology 148:74-82
31. Morimoto K, Sanei T, Sato K (1993) Comparative study of the anticonvulsant effect of gamma-aminobutyric acid agonists in the feline kindling model of epilepsy. Epilepsia 34:1123-1129
32. O'Dell LE, Li R, George FR, Ritz MC (2000) Molecular serotonergic mechanisms appear to mediate genetic sensitivity to cocaine-induced convulsions. Brain Res 863:213-224
33. Reith MEA, Meisler BE, Lajtha A (1985) Locomotor effects of cocaine, cocaine congeners, and local anesthetics in mice. Pharmacol Biochem Behav 23:831-836
34. Reith ME, Meisler BE, Sershen H, Lajtha A (1986) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 35:1123-1129
35. Rogawski MA, Porter RJ (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 42:223-286
36. Rush JM, Gibberd FB (1990) Baclofen-induced epilepsy. J R Soc Med 83:115-116
37. Sato K, Morimoto K, Okamoto M, Nakamura Y, Otsuki S, Sato M (1990) An analysis of anticonvulsant actions of GABA agonists (progabide and baclofen) in the kindling model of epilepsy. Epilepsy Res 5:117-124
38. B receptors within the rat dorsolateral septal nucleus. J Pharmacol Exp Ther 280:129-137
39. B and gamma-hydroxybutyric acid receptor antagonists. Pharmacol Biochem Behav 53:73-79
40. Snodgrass SR (1992) GABA and epilepsy: their complex relationship and the evolution of our understanding. J Child Neurol 7:77-86
41. Stripling JS, Gramlich CA, Cunningham MG (1989) Effect of cocaine and lidocaine on the development of kindled seizures. Pharmacol Biochem Behav 32:463-468
42. Tella SR, Korupolu GR, Schindler CW, Goldberg SR (1992) Pathophysiological and pharmacological mechanisms of acute cocaine toxicity in conscious rats. J Pharmacol Exp Ther 262:936-946
43. B receptor antagonists on absences and convulsive seizures. Eur J Pharmacol 332:245-255
44. Weiss SR, Post RM, Costello M, Nutt DJ, Tandeciarz S (1990) Carbamazepine retards the development of cocaine-kindled seizures but not sensitization to cocaine-induced hyperactivity. Neuropsychopharmacology 3:273-281
45. White HS (1999) Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 40:S2-S10
46. Witkin JM, Gasior M, Heifets B, Tortella FC (1999) Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine. J Pharmacol Exp Ther 289:703-711
47. Wurpel JN, Sperber EF, Moshe SL (1990) Baclofen inhibits amygdala kindling in immature rats. Epilepsy Res 5:1-7
48. Yamaguchi M, Suzuki T, Abe S, Baba A, Hori T, Okado N (2002) Repeated cocaine administration increases GABA(B(1)) subunit mRNA in rat brain. Synapse 43:175-180